BDBM581037 RFCX0139-45::US11492374, ID 18

SMILES CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](N)[C@H](C)c1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O

InChI Key InChIKey=BJEPMTPUGRJZLP-YKOZYRLUSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 581037   

TargetKappa-type opioid receptor(Homo sapiens (Human))
Humanwell Pharmaceutical Us

US Patent
LigandPNGBDBM581037(RFCX0139-45 | US11492374, ID 18)
Affinity DataIC50:  0.253nMAssay Description:The measurement of opioid receptor binding affinity was conducted using a radioligand binding assay on the membranes prepared from HEK293 cells (huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDelta-type opioid receptor(Homo sapiens (Human))
Humanwell Pharmaceutical Us

US Patent
LigandPNGBDBM581037(RFCX0139-45 | US11492374, ID 18)
Affinity DataIC50: >1.00E+4nMAssay Description:The measurement of opioid receptor binding affinity was conducted using a radioligand binding assay on the membranes prepared from HEK293 cells (huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Humanwell Pharmaceutical Us

US Patent
LigandPNGBDBM581037(RFCX0139-45 | US11492374, ID 18)
Affinity DataIC50:  9.81E+3nMAssay Description:The measurement of opioid receptor binding affinity was conducted using a radioligand binding assay on the membranes prepared from HEK293 cells (huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent